Literature DB >> 26310945

Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice.

Nicola Ivan Lorè1, Fuad A Iraqi2, Alessandra Bragonzi3.   

Abstract

BACKGROUND: Pseudomonas aeruginosa is one of the top three causes of opportunistic infections in humans. Patients with a compromised immune system, due to immunosuppressive therapies or underlying diseases such as cancer, AIDS or the hereditary disease cystic fibrosis, are at risk of developing P. aeruginosa infection. However, clinical evidence indicates extremely variable outcomes of P. aeruginosa infections in individuals at risk, suggesting that host multi-complex genetic traits may influence the severity of this opportunistic infection. Here, we have used an innovative experimental model to dissect whether host genetic background, such as those found in the outbred population, could influence the risk of morbidity and mortality to P. aeruginosa pneumonia.
RESULTS: A highly genetically-diverse mouse resource population, Collaborative Cross (CC) mice, was infected with a clinical strain of P. aeruginosa and subsequently monitored for mortality, mean survival time, and morbidity, change in body weight for seven days post infection. Disease phenotypes ranged from complete resistance and recovery of body weight to lethal disease. Initial variables, including body weight, age and gender, have limited influence on P. aeruginosa outcome, emphasizing the role of host genetic background in defining the risk of morbidity and mortality. When broad-sense heritability of phenotypic traits was evaluated, it confirmed the influence of genetic profile rather than environmental factors among the CC lines during P. aeruginosa infection.
CONCLUSION: This innovative model system can potentially reproduce the variables responses of disease severity observed in humans during P. aeruginosa pneumonia. Our results demonstrated that a widely-marked differential response to P. aeruginosa airway infection in term of morbidity and mortality, is mainly affected by host genetic factors, as multiple genetic loci or polymorphic variations.

Entities:  

Mesh:

Year:  2015        PMID: 26310945      PMCID: PMC4551369          DOI: 10.1186/s12863-015-0260-6

Source DB:  PubMed          Journal:  BMC Genet        ISSN: 1471-2156            Impact factor:   2.797


Background

Genotype is an important determinant factor in human host susceptibility to major diseases, including infections [1]. There is increasing evidence that some inter-population and inter-individual differences in the attack rate and prognosis of specific infectious organisms are due to inherited genetic variants and, for the most part, to multicomplex genetic traits (polygenetic traits) [2]. These findings are changing our view of infections as we can now assume that pathogens are not the sole determinants of the corresponding infectious diseases. Host response is influenced by the complex combinations and variations of genes, and this affects the outcome of the infectious disease. An efficient experimental method to dissect complex genetic traits still needs to be established. Recently, a new community resource - Collaborative Cross (CC) mice - has been implemented as a common platform for mammalian complex genetic traits in an attempt to overcome the limitation of existing resources [3, 4]. The CC is a murine reference population with high genetic diversity, constructed using a randomized breeding design that systematically outcrosses eight founder strains, followed by inbreeding to obtain new recombinant inbred strains. Five of the eight founders are common laboratory strains (A/J, C57BL/6 J, 129S1/SvImJ, NOD/LtJ, NZO/HiLtJ), and three are wild-derived strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ) [5]. The CC has been genotyped and showed more recombination and genetic variation compared to the other reference panels [6]. The genomes of the CC founder strains (http://www.sanger.ac.uk/resources/mouse/genomes/) and CC lines strains (http://csbio.unc.edu/CCstatus/index.py) (http://mus.well.ox.ac.uk/CC/) have been genotyped or sequenced, so it is possible to reconstruct the haplotypes of each CC line as a fixed mosaic of the founder chromosomes [6, 7]. Hallmarks of CC lines include high mapping resolution and sample sizes that are sufficient to drive phenotypic diversity in almost any trait of interest. This paper reports the use of CC mice as an innovative forward genetic approach to determine whether and to what extent host genetic background, influences the variability of P. aeruginosa acute respiratory infection. P. aeruginosa retains a prominent position as a major worldwide cause of morbidity and mortality in a wide range of patients including those with a compromised immune system from immunosuppressive therapies or underlying diseases such as cancer, AIDS or the hereditary disease, cystic fibrosis (CF) [8-10]. Clinical evidence indicates that the outcome of P. aeruginosa infections may be extremely variable among individuals at risk, suggesting that host multicomplex genetic traits may influence the severity of this opportunistic infection. Genetic mapping in the human population has been performed, but partially achieved significance in the genome-wide association study [11]. Studies from CF twins and sibs have suggested that susceptibility to chronic infection with P. aeruginosa is affected by genetic inheritance determinants, whereas initial infection is minimally influenced by genetic modifiers [12]. However, the size of the cohorts, the strong but often unknown environmental influences, poor diagnosis and lack of repeatability are bottlenecks in human studies that highlight the need for novel resources [13-15]. Mouse inbred strains are the starting point from which to explore causal genotype-phenotype relationships and identify gene mapping however they do not offer a strong tool to identify and study polymorphic variations, that are hallmarks of the human population [16, 17]. The number of classical inbred strains is relatively small. This limits genetic and phenotypic diversity and the value of Quantitative Traits Loci (QTL) detection. Thus, innovative experimental animal models are absolutely essential to complement the human studies [18]. Using CC mice, it is possible to determine genotype variation associated to disease phenotypic traits (e.g., using merge analysis) [6, 7]. Power and resolution mapping of CC mice was recently completed for host susceptibility to Aspergillus fumigatus [7], influenza A [19, 20], Klebsiella pneumoniae [21] and reported for the first time in this paper as proof-of-concept for new studies to map QTL associated with the opportunistic bacteria P. aeruginosa.

Results

Host genetic background influences the severity of P. aeruginosa pneumonia

CC lines, infected with P. aeruginosa, showed a wide-range of Survival time (ST) ranging from complete resistance (100 % survival after seven days post-infection) to lethal disease (100 % death after 1.5 days), while A/J mice showed an intermediate phenotype (30 % of mortality rate after 7 days post-infection) (Fig. 1a, Additional files 1 and 2). Similarly, CC lines had a wide variation in body weight (BW) response to P. aeruginosa infection: ranging from a 23 % decrease in BW after three days to those showing an almost total recovery of change in BW after five days (Fig. 1b). A/J mice lost 16 % of their change in BW after three days but they did not recover completely after seven days. At day 7 post-infection, bacterial cells were not recovered in the organs (blood, liver and lung) of surviving mice (data not shown), indicating that bacterial clearance is independent from differences in morbidity as assessed by recovery of body weight. These data confirm that different traits of the CC mice resource population express a wide response to P. aeruginosa infection, suggesting the key role of genetic variance on the severity of the clinical outcome.
Fig 1

Disease phenotypes in CC mice during P. aeruginosa acute respiratory infection. 17 CC lines and A/J mice of 8–14 weeks old (between 3–7 mice per Line), were inoculated with a 1×106 cfu dose of the P. aeruginosa clinical isolate AA2, and monitored for survival time ST (a) and body weight BW (b) for a period of 7 days after infection

Disease phenotypes in CC mice during P. aeruginosa acute respiratory infection. 17 CC lines and A/J mice of 8–14 weeks old (between 3–7 mice per Line), were inoculated with a 1×106 cfu dose of the P. aeruginosa clinical isolate AA2, and monitored for survival time ST (a) and body weight BW (b) for a period of 7 days after infection

Segregation analysis of disease phenotypic traits

Phenotypic traits for segregation analysis of mean survival time (MST) and change in body weight at day one (CBW1) after P. aeruginosa airway infection were selected based on previous studies with commercial inbred strains [17, 22]. Thus, segregation analysis of the phenotypic trait distributions highlights the different responses among CC lines. Figure 2 shows MST and CBW1 of the CC lines, arranged by increasing order of magnitude. Based on the statistical significance using Bonferroni’s Multiple Comparison Tests (reported in Additional file 3), CC lines were arranged by a similar variation degree of recorded traits in three groups (Fig. 2). Thus, in the high tail of MST, four CC lines (IL2156, IL521, IL2689, IL3438) were ranked with the highest MST value (MST: 5.3/7) while in the low tail, five CC lines (IL711, IL1061, IL188, IL2126, IL1912) showed the lowest MST values (MST: 1.41/1.48) (Fig. 2a). An intermediate group of eight murine lines (IL4052, IL611, IL72, IL111, IL3912, IL4457, IL4141, IL519) showed a medium MST value (MST: 1.6/4.5). Statistical analysis of CBW1 highlights a two-fold difference between the highest (IL4141, IL519, IL188; CBW1: −7.22 %/−9.33 %) and the lowest CC line groups (IL72, IL521, IL4457; CBW1: −3.16 %/−4.34 %) (Fig. 2b). An intermediate group of eleven murine lines (IL4052, IL2689, IL711, IL611, IL3912, IL3438, IL2156, IL2126, IL1061, IL1912, IL111; CBW1: −4.70 %/−6.80 %) was also recorded. Overall our data show a wide range of responses to P. aeruginosa infection, potentially caused by allelic segregations from the eight founders strains.
Fig 2

Evaluation of MST, CBW1 and H2 of CC lines after P. aeruginosa airway infection. The CC mice resource population had a strong wide-response to P. aeruginosa airway infection in the MST (a) and CBW1 traits (b). MST and CBW1 of CC lines are arranged in increasing order of mean magnitude. Based on Bonferroni's Multiple Comparison Tests (BMCT) (Additional file 3: Table S3) three distinct groups have been identified among 17 CC strains infected with P. aeruginosa and are indicated as scales of grey. Estimates of broad sense H2 (c) have been evaluated for MST and CBW1, as previously described [23]

Evaluation of MST, CBW1 and H2 of CC lines after P. aeruginosa airway infection. The CC mice resource population had a strong wide-response to P. aeruginosa airway infection in the MST (a) and CBW1 traits (b). MST and CBW1 of CC lines are arranged in increasing order of mean magnitude. Based on Bonferroni's Multiple Comparison Tests (BMCT) (Additional file 3: Table S3) three distinct groups have been identified among 17 CC strains infected with P. aeruginosa and are indicated as scales of grey. Estimates of broad sense H2 (c) have been evaluated for MST and CBW1, as previously described [23]

Effect of initial body weight, age and gender on disease phenotypes

The effects of initial body weight or age on ST, CBW1 were tested across 17 CC lines and A/J mice; they were found not to be significant by Spearman‘s Correlation (Table 1A). Similarly, gender effect on ST and CBW1 was not significantly correlated when the whole murine population was considered. Within individual CC lines no significant gender effect on disease phenotypes was observed among male and female mice (Table 1B), although a limited number of animals was consider. All together these results, emphasize the key role of genetic determinants in the severity and in the outcome of P. aeruginosa airway infections using this diverse murine population.
Table 1

Analysis of initial body weight, age and gender on disease phenotypes

ASurvival Time (n = 92)Change in BW day 1 (n = 92)
Initial body weight r = 0.192 P > 0.05 r = 0.010 P > 0.05
Week’s old r = 0.099 P > 0.05 r = 0.173 P > 0.05
Gender r = 0.070 P > 0.05 r = 0.035 P > 0.05
B
Mean Survival Time
MaleFemaleANOVA
MeanSEMnMeanSEMnP value
A/J1.830.6034.671.066P > 0.05
IL 40521.830.3331.500.003P > 0.05
IL 34387.000.0037.000.003P > 0.05
IL 21567.000.0033.671.693P > 0.05
IL 7111.500.0021.300.125P > 0.05
IL 21261.500.0041.500.002P > 0.05
IL 41414.252.7524.501.464P > 0.05
IL 44575.171.3632.500.002P > 0.05
IL 19121.170.1732.000.503P > 0.05
% Change in body weight day 1
MaleFemaleANOVA
MeanSEMnMeanSEMnP value
A/J−10.535.902−11.301.115P > 0.05
IL 4052−3.050.943−6.370.913P > 0.05
IL 3438−6.520.793−4.280.473P > 0.05
IL 2156−5.691.753−5.181.413P > 0.05
IL 711−5.131.302−5.101.232P > 0.05
IL 2126−6.181.194−5.150.492P > 0.05
IL 4141−8.451.272−6.620.434P > 0.05
IL 4457−3.761.413−5.232.032P > 0.05
IL 1912−6.360.001−6.290.593P > 0.05

Overall Spearman‘s correlation (r correlation coefficients and P value) between all the initial parameters (initial BW, week’s old and gender) of CC lines and recorded traits (ST: n = 92, CBW1: n = 92) to determine potential influence (A). Two-way ANOVA’s comparison across eight selected CC lines and A/J commercial inbred line to evaluate gender influence on recorded traits (MST and CWB1) (B)

Analysis of initial body weight, age and gender on disease phenotypes Overall Spearman‘s correlation (r correlation coefficients and P value) between all the initial parameters (initial BW, week’s old and gender) of CC lines and recorded traits (ST: n = 92, CBW1: n = 92) to determine potential influence (A). Two-way ANOVA’s comparison across eight selected CC lines and A/J commercial inbred line to evaluate gender influence on recorded traits (MST and CWB1) (B)

Heritability of disease phenotypes during P. aeruginosa pneumonia

To test if the traits variations within the infected CC murine population were due to genetic factors, we estimated heritability as described [23, 24]. Broad-sense heritability (H2) was calculated for all the CC lines for which MST and CBW1 were recorded (Fig. 2c). Estimated H2 was 0.54 and 0.28 for MST and CBW1, respectively. Thus, on observation of the CC lines during P. aeruginosa infection, there is a clear host response that is affected by the genetic components as opposed to the purely environmental factors.

Discussion

Several studies highlight how host response to infection may be strongly influenced by the cumulative effect and interactions of multiple genetic loci and by a complex set of other factors (e.g. the environment, the bacterial strain and origin, age and gender) [1, 13, 25]. Among the most relevant infectious diseases that affect humans, P. aeruginosa shows a wide variation in the clinical outcome in individuals at risk [8-10], indicating that the host-response may contribute to the variation of morbidity and mortality. However, predictive experimental animal models to dissect complex genetic traits, such as multiple genetic loci, that can influence the outcome of P. aeruginosa respiratory infection, remain to be established. To date, a poor phenotype/genotype correlation in human studies and the lack of a fully faithful mouse model have limited scientific advancements in the field [13-15]. To meet the current challenge of complex trait analysis, we used CC mice to evaluate the contribution of the host to P. aeruginosa pathogenicity. First, based on phenotypic diversity of human response to infection, we defined two end-points (ST and BW) that may ultimately have clinical relevance in term of morbidity and mortality. Based on previous studies with commercial inbred strains [17, 22], MST and CBW1 were selected as phenotypic disease traits to perform segregation analysis. Our approach generated wide-marked range of phenotypic differences in terms of MST and CBW1 during P. aeruginosa pneumonia, although a limited number of lines were considered. On the other, future experiments will define detailed phenotypic traits, such as bacterial load, inflammatory cytokines or cellular recruitment into the lung. Next, initial variables - including body weight, age and gender - have limited influence on P. aeruginosa outcome, emphasizing the key role of genetic determinants in the disease severity in our infectious model system. In addition, the high value of the broad-sense heritability of the two recorded disease phenotypic traits support our suggestion that host genotype is an important determinant factor in the disease’s severity. A similar approach was developed using Diversity Outbred mice to model Staphylococcus aureus and influenza Virus pneumonia [26]. Interestingly, they demonstrated that initial body weight correlated with viral burden, including co-infected mice, but not with S. aureus bacterial load. These suggest that the correlation of initial body weight and infectious graveness is modulated by the specific host-pathogen interplay. Both host genetic background and type of pathogen may have a key role in determining morbidity. Of relevance, the power of CC population as model system relies also in the fact that all potential co-variables, that may influence phenotypic traits, are taken into account in the statistical analysis. Thus for future mapping of key genetic loci/genes, by using CC population and model of airway infection, we can track the influence of confounding effects that are bottlenecks in genetic mapping in the human population.

Conclusions

Exploring CC mouse population together with a model of respiratory infection, our results demonstrates that P. aeruginosa opportunistic infection has wide range of disease phenotypes affected by multiple host genetic factors, such as multiple genetic loci or polymorphic variations. Future mapping of key genetic loci/genes involved in the P. aeruginosa infection will be carried out with the use of additional CC lines and further traits of disease phenotypes will be assessed. This innovative approach, based on the concept of forward genetics, will provide new insight into the key molecular processes that control host/pathogen interactions in respiratory disease, and should reveal novel targets for human personalized therapeutic strategies.

Material and methods

Ethic statement

All experimental mice and protocols were approved by the Institutional Animal Care and Use Committee of Tel Aviv University (TAU) (approval number: M-13-079). P. aeruginosa clinical isolate AA2 was obtained from CF patient attending the Medizinische Hochschule of Hannover, Germany and described previously [17, 22, 27]. Research on the bacterial isolates from the individual with CF has been approved by the responsible physician at the CF center at Hannover Medical School, Germany. Patient gave informed consent before the sample collection. Approval for storing of biological materials was obtained by the Hannover Medical School, Germany.

Collaborative cross and inbred lines

A total of 92 (50 Males, 42 Females) mice (8 to 14-week old) from 17 different CC mouse lines (average 3–7 mice per line) were provided by the Small Animal Facility at Sackler Faculty of Medicine, Tel Aviv University (TAU). The lines were at inbreeding generations F20-F39, minimum 90 % homozygosity. Full details of the development of these CC lines are given in Welsh et al. [3, 28]. In addition to the CC mice, commercially inbred lines, A/J mice were used as internal control and were was purchased from Jackson Laboratory. The infection challenge was carried out at the BSL-2 laboratory at TAU. Mice were housed on hardwood chip bedding in open-top cages at the animal facility and were given tap water and rodent chow ad libitum. After P. aeruginosa infection, mice were monitored twice per day for the parameters vocalisation, piloerection, attitude, locomotion, breathing, curiosity, nasal secretion, grooming and dehydration. Mice that lost >25 % body weight and had evidence of severe clinical disease, such as scruffy coat, inactivity, loss of appetite, poor locomotion, or painful posture, were sacrificed before the termination of the experiments with an overdose of carbon dioxide.

P. aeruginosa strain and mouse model of acute respiratory infection

Prior to the animal experiments, P. aeruginosa AA2 clinical strain was grown in Trypticase Soy Broth (TSB) to reach the exponential phase at 37 °C [22, 27]. The mice were anesthetized and infected by intratracheal injection with a 106 colony forming unit (cfu) implanted into the lung via the cannula, with all lobes inoculated as described [22]. ST and BW of mice were monitored daily over one week; then the surviving mice were euthanized and tested for cfu in blood, liver and lung.

Disease phenotypic traits and segregation analysis

ST and BW of mice were considered as disease phenotypic traits for mortality and morbidity of P. aeruginosa pneumonia. In particular, MST and CBW1 were selected for segregation analysis, based on previous studies with commercial inbred strains [17, 22]. At day one post P. aeruginosa infection, a high decrease of body weight associated to low mortality rate was reported [17, 22]. Based on the statistical significance, using Bonferroni’s Multiple Comparison Tests (reported in Additional file 3), CC lines were arranged in three groups for MTS and CBW1 by increasing order of magnitude, as described [24].

Estimation of heritability

Broad sense heritability - including epistatic but not dominance effects for MST and CBW1 - was calculated across the CC lines under P. aeruginosa infection and in naïve conditions as described [23]. Briefly, One-way ANOVA by CC line was implemented separately for MST and CBW1. Based on these analyses, broad sense heritability (H2), was calculated across the CC lines under control and challenge conditions, separately.

Statistical analysis

Spearman‘s correlation was used for associations tests. One- and Two-ANOVA and Bonferroni’s Multiple Comparison Tests were used to determine the statistical significance, using GraphPad software.
  28 in total

1.  The Collaborative Cross, a community resource for the genetic analysis of complex traits.

Authors:  Gary A Churchill; David C Airey; Hooman Allayee; Joe M Angel; Alan D Attie; Jackson Beatty; William D Beavis; John K Belknap; Beth Bennett; Wade Berrettini; Andre Bleich; Molly Bogue; Karl W Broman; Kari J Buck; Ed Buckler; Margit Burmeister; Elissa J Chesler; James M Cheverud; Steven Clapcote; Melloni N Cook; Roger D Cox; John C Crabbe; Wim E Crusio; Ariel Darvasi; Christian F Deschepper; R W Doerge; Charles R Farber; Jiri Forejt; Daniel Gaile; Steven J Garlow; Hartmut Geiger; Howard Gershenfeld; Terry Gordon; Jing Gu; Weikuan Gu; Gerald de Haan; Nancy L Hayes; Craig Heller; Heinz Himmelbauer; Robert Hitzemann; Kent Hunter; Hui-Chen Hsu; Fuad A Iraqi; Boris Ivandic; Howard J Jacob; Ritsert C Jansen; Karl J Jepsen; Dabney K Johnson; Thomas E Johnson; Gerd Kempermann; Christina Kendziorski; Malak Kotb; R Frank Kooy; Bastien Llamas; Frank Lammert; Jean-Michel Lassalle; Pedro R Lowenstein; Lu Lu; Aldons Lusis; Kenneth F Manly; Ralph Marcucio; Doug Matthews; Juan F Medrano; Darla R Miller; Guy Mittleman; Beverly A Mock; Jeffrey S Mogil; Xavier Montagutelli; Grant Morahan; David G Morris; Richard Mott; Joseph H Nadeau; Hiroki Nagase; Richard S Nowakowski; Bruce F O'Hara; Alexander V Osadchuk; Grier P Page; Beverly Paigen; Kenneth Paigen; Abraham A Palmer; Huei-Ju Pan; Leena Peltonen-Palotie; Jeremy Peirce; Daniel Pomp; Michal Pravenec; Daniel R Prows; Zhonghua Qi; Roger H Reeves; John Roder; Glenn D Rosen; Eric E Schadt; Leonard C Schalkwyk; Ze'ev Seltzer; Kazuhiro Shimomura; Siming Shou; Mikko J Sillanpää; Linda D Siracusa; Hans-Willem Snoeck; Jimmy L Spearow; Karen Svenson; Lisa M Tarantino; David Threadgill; Linda A Toth; William Valdar; Fernando Pardo-Manuel de Villena; Craig Warden; Steve Whatley; Robert W Williams; Tim Wiltshire; Nengjun Yi; Dabao Zhang; Min Zhang; Fei Zou
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

Review 2.  Controlling complexity: the clinical relevance of mouse complex genetics.

Authors:  Klaus Schughart; Claude Libert; Martien J Kas
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

Review 3.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.

Authors:  Shaan L Gellatly; Robert E W Hancock
Journal:  Pathog Dis       Date:  2013-03-15       Impact factor: 3.166

Review 4.  After GWAS: mice to the rescue?

Authors:  Joerg Ermann; Laurie H Glimcher
Journal:  Curr Opin Immunol       Date:  2012-09-29       Impact factor: 7.486

5.  The Collaborative Cross, developing a resource for mammalian systems genetics: a status report of the Wellcome Trust cohort.

Authors:  Fuad A Iraqi; Gary Churchill; Richard Mott
Journal:  Mamm Genome       Date:  2008-06-03       Impact factor: 2.957

Review 6.  Human genetic susceptibility to infectious disease.

Authors:  Stephen J Chapman; Adrian V S Hill
Journal:  Nat Rev Genet       Date:  2012-02-07       Impact factor: 53.242

7.  Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.

Authors:  Martin T Ferris; David L Aylor; Daniel Bottomly; Alan C Whitmore; Lauri D Aicher; Timothy A Bell; Birgit Bradel-Tretheway; Janine T Bryan; Ryan J Buus; Lisa E Gralinski; Bart L Haagmans; Leonard McMillan; Darla R Miller; Elizabeth Rosenzweig; William Valdar; Jeremy Wang; Gary A Churchill; David W Threadgill; Shannon K McWeeney; Michael G Katze; Fernando Pardo-Manuel de Villena; Ralph S Baric; Mark T Heise
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

8.  Genotype is an important determinant factor of host susceptibility to periodontitis in the Collaborative Cross and inbred mouse populations.

Authors:  Ariel Shusterman; Yasser Salyma; Aysar Nashef; Morris Soller; Asaf Wilensky; Richard Mott; Ervin I Weiss; Yael Houri-Haddad; Fuad A Iraqi
Journal:  BMC Genet       Date:  2013-08-09       Impact factor: 2.797

Review 9.  The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host.

Authors:  Eirini Christaki; Evangelos J Giamarellos-Bourboulis
Journal:  Virulence       Date:  2013-09-25       Impact factor: 5.882

10.  Susceptibility to Klebsiella pneumonaie infection in collaborative cross mice is a complex trait controlled by at least three loci acting at different time points.

Authors:  Karin Vered; Caroline Durrant; Richard Mott; Fuad A Iraqi
Journal:  BMC Genomics       Date:  2014-10-06       Impact factor: 3.969

View more
  24 in total

Review 1.  High-Diversity Mouse Populations for Complex Traits.

Authors:  Michael C Saul; Vivek M Philip; Laura G Reinholdt; Elissa J Chesler
Journal:  Trends Genet       Date:  2019-05-24       Impact factor: 11.639

2.  Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b.

Authors:  Caroline Manet; Etienne Simon-Lorière; Grégory Jouvion; David Hardy; Matthieu Prot; Laurine Conquet; Marie Flamand; Jean-Jacques Panthier; Anavaj Sakuntabhai; Xavier Montagutelli
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

Review 3.  The Collaborative Cross mouse model for dissecting genetic susceptibility to infectious diseases.

Authors:  Hanifa Abu Toamih Atamni; Aysar Nashef; Fuad A Iraqi
Journal:  Mamm Genome       Date:  2018-08-24       Impact factor: 2.957

Review 4.  These Are the Genes You're Looking For: Finding Host Resistance Genes.

Authors:  Jeffrey S Bourgeois; Clare M Smith; Dennis C Ko
Journal:  Trends Microbiol       Date:  2020-09-29       Impact factor: 17.079

5.  Mapping genetic determinants of host susceptibility to Pseudomonas aeruginosa lung infection in mice.

Authors:  Maura De Simone; Lorenza Spagnuolo; Nicola Ivan Lorè; Cristina Cigana; Ida De Fino; Karl W Broman; Fuad A Iraqi; Alessandra Bragonzi
Journal:  BMC Genomics       Date:  2016-05-11       Impact factor: 3.969

6.  Dissecting the Effect of Genetic Variation on the Hepatic Expression of Drug Disposition Genes across the Collaborative Cross Mouse Strains.

Authors:  Aharon Nachshon; Hanifa J Abu-Toamih Atamni; Yael Steuerman; Roa'a Sheikh-Hamed; Alexandra Dorman; Richard Mott; Juliane C Dohm; Hans Lehrach; Marc Sultan; Ron Shamir; Sascha Sauer; Heinz Himmelbauer; Fuad A Iraqi; Irit Gat-Viks
Journal:  Front Genet       Date:  2016-10-05       Impact factor: 4.599

7.  The host genetic background defines diverse immune-reactivity and susceptibility to chronic Pseudomonas aeruginosa respiratory infection.

Authors:  Lorenza Spagnuolo; Maura De Simone; Nicola Ivan Lorè; Ida De Fino; Veronica Basso; Anna Mondino; Cristina Cigana; Alessandra Bragonzi
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

8.  Extensive Homeostatic T Cell Phenotypic Variation within the Collaborative Cross.

Authors:  Jessica B Graham; Jessica L Swarts; Michael Mooney; Gabrielle Choonoo; Sophia Jeng; Darla R Miller; Martin T Ferris; Shannon McWeeney; Jennifer M Lund
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

9.  Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection.

Authors:  Nicola Ivan Lorè; Noemi Veraldi; Camilla Riva; Barbara Sipione; Lorenza Spagnuolo; Ida De Fino; Medede Melessike; Elisa Calzi; Alessandra Bragonzi; Annamaria Naggi; Cristina Cigana
Journal:  Int J Mol Sci       Date:  2018-01-09       Impact factor: 5.923

10.  Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis.

Authors:  Julie Ng; Fei Guo; Anna E Marneth; Sailaja Ghanta; Min-Young Kwon; Joshua Keegan; Xiaoli Liu; Kyle T Wright; Baransel Kamaz; Laura A Cahill; Ann Mullally; Mark A Perrella; James A Lederer
Journal:  Blood Adv       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.